Harrow, Inc. 8.625% Senior Notes due 2026

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch HROWL and buy or sell other stocks, ETFs, and their options commission-free!

About HROWL

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. 

CEO
Mark L. Baum
CEOMark L. Baum
Employees
—
Employees—
Headquarters
Nashville, Tennessee
HeadquartersNashville, Tennessee
Founded
2006
Founded2006
Employees
—
Employees—

HROWL Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
12.63K
Average volume12.63K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$25.72
52 Week high$25.72
52 Week low
$25.00
52 Week low$25.00

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.